Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

NCT02445404 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma

Interventions

DRUG: CHOP
DRUG: fractionated ICED

Sponsor

Samsung Medical Center